• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Simulations Plus, Inc. - Common Stock (NQ:SLP)

    13.11 +0.07 (+0.54%)
    Streaming Delayed Price Updated: 12:36 PM EDT, Apr 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Simulations Plus, Inc. - Common Stock

    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 Next >
    News headline image
    Recap: Simulations Plus Q3 Earnings ↗
     
    Via Benzinga
    News headline image
    Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus's Earnings: A Preview ↗
     
    Via Benzinga
    News headline image
    Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Is High-Growth Investment Opportunity In The Wake Of Immunetrics Acquisition: Analyst ↗
    Oppenheimer analyst Francois Brisebois reiterated an Outperform rating on the shares of Simulations Plus, Inc. (NASDAQ: SLP),  
    Via Benzinga
    News headline image
    Preview: Simulations Plus's Earnings ↗
     
    Via Benzinga
    News headline image
    Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    7 Stocks Under $50 to Buy (and Never Sell) ↗
    Although you usually get what you pay for, these best affordable stocks to invest in punch above their weight class. 
    Via InvestorPlace
    News headline image
    Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023 ↗
     
    Via Benzinga
    News headline image
    Roblox And 3 Other Stocks Insiders Are Selling ↗
    The Nasdaq Composite closed sharply higher on Thursday. Investors, meanwhile, focused on some notable insider trades. 
    Via Benzinga
    News headline image
    Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus to Present at Sidoti March Small-Cap Conference
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
    Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
      On Thursday, 63 companies set new 52-week lows. 
    Via Benzinga
    News headline image
    Constellation Brands, Walgreens, RPM International And Some Other Big Stocks Moving Lower On Thursday ↗
    U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    News headline image
    Simulations Plus Reports First Quarter Fiscal 2023 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    News headline image
    Earnings Scheduled For January 4, 2023 ↗
    Companies Reporting Before The Bell • UniFirst (NYSE:UNF) is likely to report quarterly earnings at $1.94 per share on revenue of $527.51 million. 
    Via Benzinga
    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.